Evidence map›Paper›PMID 30988429›Full record

ArticleNature microbiology2019

Basal expression of interferon regulatory factor 1 drives intrinsic hepatocyte resistance to multiple RNA viruses.

Daisuke Yamane, Hui Feng, Efraín E Rivera-Serrano, Sara R Selitsky, Asuka Hirai-Yuki, Anshuman Das, Kevin L McKnight, Ichiro Misumi, Lucinda Hensley, William Lovell and 14 more

Abstract read
In one paragraph

Article in Nature microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 79 papers.

0numbers the graph read from it
0cells of the map it votes in
79citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

79 citing papers in PubMed, 111 citations in OpenAlex.

  1. Article
  2. Differential regulation of basal and interferon-inducedAmerican journal of physiology. Renal physiology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. The low-density lipoprotein receptor LDLR mediates cellular entry of nonenveloped hepatitis A virus.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  10. Article
  11. Review
  12. Intrinsic OASL expression governs heterogeneity in interferon induction during influenza A virus infection.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Interferon-Based Therapeutics in Cancer Therapy: Past, Present, and Future.International journal of molecular sciences · 2025
    Review
  19. Article
  20. Article

19 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 7 institutions in 2 countries.

Daisuke YamaneUNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA. yamane-ds@igakuken.or.jp.ORCID http://orcid.org/0000-0003-1592-9368
Hui FengUNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.
Efraín E Rivera-SerranoUNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.
Sara R SelitskyUNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.
Asuka Hirai-YukiUNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.
Anshuman DasUNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.
Kevin L McKnightUNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.
Ichiro MisumiDepartment of Microbiology, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Lucinda HensleyUNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.
William LovellUNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.ORCID http://orcid.org/0000-0001-8625-6581
Olga González-LópezUNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.
Ryosuke SuzukiDepartment of Virology II, National Institute of Infectious Diseases, Shinjuku-ku, Tokyo, Japan.
Mami MatsudaDepartment of Virology II, National Institute of Infectious Diseases, Shinjuku-ku, Tokyo, Japan.
Hiroki NakanishiResearch Center for Biosignaling, Akita University,, Akita, Japan.
Takayo Ohto-NakanishiLipidome Lab Co., Ltd,, Akita, Japan.
Takayuki HishikiDepartment of Microbiology and Cell Biology, Tokyo Metropolitan Institute of Medical Science, Setagaya-ku, Tokyo, Japan.
Eliane WauthierUNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.
Tsunekazu OikawaUNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.
Kouichi MoritaDepartment of Virology, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan.
Lola M ReidUNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.
Praveen SethupathyUNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.
Michinori KoharaDepartment of Microbiology and Cell Biology, Tokyo Metropolitan Institute of Medical Science, Setagaya-ku, Tokyo, Japan.
Jason K WhitmireUNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.ORCID http://orcid.org/0000-0003-2578-6073
Stanley M LemonUNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA. smlemon@med.unc.edu.ORCID http://orcid.org/0000-0003-1450-806X
University of North Carolina at Chapel Hill · USNational Institute of Infectious Diseases · JPTokyo Metropolitan Institute of Medical Science · JPAkita University · JPCornell University · USNagasaki University · JPUNC Lineberger Comprehensive Cancer Center

Funding

Virology Research Program (Program 4)P30CA016086 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Deborah F. Tate · 1985 to 2026
$201.5M
Proteomics Pathway DiscoveryU19AI109965 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DUNCAN, JOSEPH A · 2014 to 2018
$14.9M
Membrane Hijacking: Biogenesis and Fate of Quasi-Enveloped HepatovirusR01AI103083 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI LEMON, STANLEY M. · 2012 to 2021
$4.0M
Murine Model of Human Hepatitis AR01AI131685 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI LEMON, STANLEY M., WHITMIRE, JASON KYLE · 2017 to 2021
$1.9M
NCI NIH HHS P30 CA016086NIAID NIH HHS R01 AI103083NIAID NIH HHS R01 AI131685NIAID NIH HHS U19 AI109965
6 · The paper itself

Abstract

Current models of cell-intrinsic immunity to RNA viruses centre on virus-triggered inducible antiviral responses initiated by RIG-I-like receptors or Toll-like receptors that sense pathogen-associated molecular patterns, and signal downstream through interferon regulatory factors (IRFs), transcription factors that induce synthesis of type I and type III interferons

Indexed as

Gene ExpressionAnimalsCell NucleusCells, CulturedFecesGene Expression ProfilingGene Expression RegulationGene Knockout TechniquesHepatocytesHumansImmunity, InnateInterferon Regulatory Factor-1KineticsLiverMiceRNA, Small InterferingInterferon Regulatory Factor-1RNA, Small Interfering

Identifiers

PMID30988429
PMCPMC6588457
OpenAlexW2938893974

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.